Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DIA-VIT

Financiado

Cerrado

DIA VIT a non invasive glucose self monitoring device for diabetes patients

DIA-VIT is a first non-invasive glucose self-monitoring device for diabetes patients, with proven operational results. We have designed and produced our own unique innovative modules and developed the algorithm supporting the devi... ver más

31/10/2015

VB Center

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

VB CENTER D.O.O. No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2015-10-31

PHC-12-2015-1: Clinical research for the validatio...

I+D

Cerrada hace 9 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

VB Center

50.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

NiGlucoMon A Non Invasive GLUCOse MONitoring device for diabetics based... 71K€ Cerrado

PLAN DE INTERNACIONALIZACIÓN PARA LOS PRODUCT... PLAN DE INTERNACIONALIZACIÓN PARA LOS PRODUCTOS DE MONITORIZ... 243K€ Cerrado

PTQ2023-013156 Nuevas herramientas biosensoras para el diagnóstico remoto,... 109K€ Cerrado

PTQ2021-012005 Nuevas herramientas biosensoras para el diagnóstico remoto,... 100K€ Cerrado

WASP Wide Spectral Range Photonic Glucometer 150K€ Cerrado

GlucoTear Non Invasive Fluorescence based Tear Glucose Sensor Integrat... 170K€ Cerrado

Duración del proyecto: 2 meses Fecha Inicio: 2015-08-21
Fecha Fin: 2015-10-31

Líder del proyecto

VB CENTER D.O.O. No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto DIA-VIT is a first non-invasive glucose self-monitoring device for diabetes patients, with proven operational results. We have designed and produced our own unique innovative modules and developed the algorithm supporting the device. Our device was tested and proved in relevant environment and is at TRL 6 stage according to Technology Readiness Level table. Technology of DIA-VIT device is extremely disruptive by nature. Although there have been several trials over the years, technology for monitoring glucose has not changed for more than 30 years. All existing technologies are invasive. Key market application of our device is direct replacement of current generation of self-monitoring devices for glucose measurement. On the basis of the patent search we believe that we have freedom to operate and that we do not breach any other patent rights. Today 387 million people in the world are suffering from diabetes and the number is rising. The global market of self-monitoring devices will reach $12.2 billion by the year 2017. DIA-VIT device will increase quality of life for diabetes patients, enable early, simple and accurate diagnostic and reduce costs of the diabetes health care. Our innovation will represent business opportunity for producers/suppliers and distributors of the device. Target users for DIA-VIT device are diabetes patients, physically active and quality-of-life-aware population. Market segment is age 25-45, geographical areas are developed markets of EU and US, and later on also other markets. The entrepreneurial team who worked together towards the currently developed minimum viable product consists of experts from different fields (R&D, sales, marketing, finance). Within Feasibility study we will assess technical, operational, legal, timing aspects of the project and develop business model and commercialization plan. We are determined to bring the DIA-VIT non-invasive glucose self-monitoring device to market.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores